Status:
UNKNOWN
Pilot Study of Immediate HIV Treatment in Guangxi, China
Lead Sponsor:
National Center for AIDS/STD Control and Prevention, China CDC
Collaborating Sponsors:
Guangxi Center for Disease Control and Prevention
AbbVie
Conditions:
HIV
Acquired Immunodeficiency Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the study is to measure the effectiveness of a pilot program in Guangxi, China to decrease mortality related to HIV. The study's proposed mechanism of decreasing mortality rates is to shor...
Detailed Description
The aim of the study is to measure the effectiveness of a pilot program in Guangxi, China to decrease mortality related to HIV/AIDS. In past years, Guangxi has experienced a relatively high rate of la...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- New diagnosis of HIV infection as defined by having positive HIV antibody screening results between July 1, 2012 and July 1, 2015 OR
- Having a current residential address inside of pilot site limits
- Exclusion criteria:
- Current residing outside of the borders of the designated study sites
Exclusion
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01892228
Start Date
July 1 2012
End Date
July 1 2015
Last Update
May 12 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pubei Center for Disease Control
Xiaojiang, Guangxi, China
2
Zhongshan Center for Disease Control
Zhongshan, China